THE POWER of PROPAGANDA ? Compiled by Margaret Williams 4Th February 2017 for the Last 48 Years
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Advances in Me/Cfs Research and Clinical Care
ADVANCES IN ME/CFS RESEARCH AND CLINICAL CARE EDITED BY : Kenneth J. Friedman, Lucinda Bateman, Alison Bested and Zaher Nahle PUBLISHED IN : Frontiers in Pediatrics and Frontiers in Neurology Frontiers eBook Copyright Statement About Frontiers The copyright in the text of individual articles in this eBook is the Frontiers is more than just an open-access publisher of scholarly articles: it is a property of their respective authors or their respective institutions or pioneering approach to the world of academia, radically improving the way scholarly funders. The copyright in graphics research is managed. The grand vision of Frontiers is a world where all people have and images within each article may be subject to copyright of other an equal opportunity to seek, share and generate knowledge. Frontiers provides parties. In both cases this is subject immediate and permanent online open access to all its publications, but this alone to a license granted to Frontiers. is not enough to realize our grand goals. The compilation of articles constituting this eBook is the property of Frontiers. Frontiers Journal Series Each article within this eBook, and the eBook itself, are published under The Frontiers Journal Series is a multi-tier and interdisciplinary set of open-access, the most recent version of the Creative Commons CC-BY licence. online journals, promising a paradigm shift from the current review, selection and The version current at the date of dissemination processes in academic publishing. All Frontiers journals are driven publication of this eBook is CC-BY 4.0. If the CC-BY licence is by researchers for researchers; therefore, they constitute a service to the scholarly updated, the licence granted by community. -
Sensationalism Versus Science?
Sensationalism versus Science? Malcolm Hooper and Margaret Williams 5th May 2013 The long-promised article by Michael Hanlon on the “war” surrounding the neuroimmune disorder myalgic encephalomyelitis (ME) was published today in the Sunday Times Magazine together with a photograph of Professor Sir Simon Wessely (“This man faced death threats and abuse. His crime? He suggested that ME was a mental illness”). Whilst the article focuses on the unacceptable actions of very few alleged sufferers and not on legitimate challenges mounted by scientists, it may be of interest to reproduce the questions which Hanlon sent to Professor Malcolm Hooper on 31st January and also Professor Hooper’s reply, since that reply provides the backdrop to the on-going “war”. First, though, it must be said that much of Hanlon’s article is factually wrong. For example, Hanlon begins his article with the assertion that “Professor Sir Simon Wessely lives on the front line of science”,which immediately reveals a lack of understanding in that Sir Simon does not live on the front line of biomedical science but on the front line of psychiatry, a discipline with no biomarkers of disease. Indeed Sir Simon ignores, actively denies or dismisses the evidence of biomedical scientists that demonstrates whole-body inflammation in ME and does not accept that it has now been shown to be an autoimmune disease. Hanlon goes on to state that Sir Simon “has done a lot of work for the military, helping to treat traumatised war veterans”, when there is irrefutable published evidence that Sir Simon has for decades denied the very existence of Gulf War Syndrome. -
New ME Briefing 21 J
1 Briefing for ‘Myalgic Encephalomyelitis: Treatment st and Research’ Westminster Hall, 21 June 2018 Contents About ME 3 The Debate 3 Education of health professionals 4 Review of the NICE guideline on ME/CFS 5 NHS services 6 Children and young people with ME 7 Severe ME 7 Biomedical research 8 PACE trial 10 ME and welfare benefits 10 Social Care 11 References 13 Contact details 15 Appendix: The PACE Trial Controversy 16 This briefing has been produced jointly by #MEAction, Action for M.E., ME Association and the ME Trust (for contact details, see page 15) Supported by: Blue Ribbon for Awareness of ME, Centre for Welfare Reform, Forward-ME, ME Research UK, WAMES 2 A bout ME Myalgic Encephalomyelitis (ME) is a chronic, fluctuating, neurological condition that causes symptoms affecting many body systems, more commonly the nervous and immune systems. ME affects an estimated 250,000 adults and children in the UK, and around 17 million people worldwide. People with ME experience severe, persistent fatigue associated with post-exertional malaise (PEM), their systems’ inability to recover after expending even small amounts of energy, leading to a flare-up in symptoms. PEM means that simple mental or physical activities can leave people with ME debilitated, experiencing a range of symptoms that are not significantly relieved by resting. PEM is the hallmark symptom of ME, other symptoms can include muscle and joint pain, cognitive difficulties, noise and light sensitivities and digestive problems. People with ME can vary enormously in their experience of the illness, and how their symptoms fluctuate. An estimated one in four children and adults with ME experience these symptoms severely (see ‘Severe ME’ on page 7). -
Straight-Jacketed by Empty Air
Straight-jacketed by empty air Psychiatry’s long and shameful involvement in Myalgic Encephalomyelitis St Straight-jacketed by empty air Greg Crowhurst Please note that the publisher and the author cannot be held accountable for any damages or actions arising from reading this book, which is presented for informational purposes only. It is not intended as a substitute for professional medical advice. The views of contributors are not necessarily those of the publisher or author, under no circumstances can they be held accountable for any loss or claim arising out of the opinions expressed or suggestions made. “There is no doubt that ME is an organic disorder. The sufferers are denied proper recognition, misdiagnosed, vilified, ridiculed and driven to great depths of despair.” Hansard (House of Commons) 23rd February 188/columns 167-168 Books by Greg Crowhurst : Kevin Mayhew : St Pauls : Holy Way , Stonebird S Stonebird Holy Way Dedication I dedicate this, with all the love in my heart to my wife Linda, whose agony is beyond imagination or comprehension. All I have to help are these arms to reach out, hold and comfort, but that is more and more unbearable for her to cope with, so severe is her torture. Acknowledgements: Many, many thanks for all the support and enthusiasm for this book, it spurred me on! Special thanks to Rachel Higginson, Susanna Agardy, Geoffrey Keith Brown, Sally K Burch, Colleen Steckel, Nancy Blake, Corina Duyn, Clare Norton, Naomi Whittingham and Theresa Brennan. “I must emphasise that the most important message -
The Biopolitics of Chronic Fatigue Syndrome
The Biopolitics of Chronic Fatigue Syndrome Thesis submitted for the degree of Doctor of Philosophy at the University of Leicester by Nikos Karfakis School of Management University of Leicester March 2013 Abstract The Biopolitics of Chronic Fatigue Syndrome by Nikos Karfakis This thesis approaches Chronic Fatigue Syndrome (CFS) as a biopolitical problem, that is as a shifting scientific object which needs to be studied, classified and regulated. Assemblages of authorities, knowledges, and techniques make CFS subjects and shape their everyday conduct in an attempt to increase their supposed autonomy, wellbeing and health. CFS identities are, however, made not only through government, scientific and medical interventions but also by the patients themselves, a biosocial community that collaborates with scientists, educates itself about the intricacies of biomedicine, and contests psychiatric truth claims. CFS is a socio-medical disorder, an illness trapped between medicine, psychology and society, an illness that is open to debate, and therefore difficult to manage and standardise. CFS is, thus, more than a fixed and defined medical category; it is a performative and multiple category, it is a heterogeneous world. This thesis studies that performative complexity by assembling different pieces of empirical data that constitute its heterogeneity: medical and psychiatric journals and monographs, self-help books, CFS organisations’ magazines, newsletters and websites, illness narratives and social studies of CFS, CFS blogs, and qualitative interviews with diagnosed CFS patients and CFS activists. The thesis delineates different interventions by medicine, science, the state and the patients themselves and concludes that CFS remains elusive, only partially standardised, in an on- going battle between all the different actors that want to define it for their own situated interests. -
Journal of Iime Volume 1 Issue 1 2
JJJooouuurrrnnnaaalll ooofff IIIiiiMMMEEE IIInnnvvveeesssttt iiinnn MMMEEE IIInnnttteeerrrnnnaaatttiiiooonnnaaalll MMMEEE///CCCFFFSSS CCCooonnnfffeeerrreeennnccceee 222000000777 SSSpppeeeccciiiaaalll VOLUME 1 ISSUE 1 Invest in ME Charity Nr 1114035 www.investinme.org Journal of IiME Volume 1 Issue 1 2 Welcome from Invest in ME Welcome to the first Journal of Invest in ME – a combination of research, information, news, stories and other articles relating to myalgic encephalomyelitis (ME). Facts About ME This first version is also serving a dual purpose in that it is acting as a An estimated 250,000 component of the delegate’s conference pack for the 2nd Invest in ME International ME/CFS Conference 2007, held in Westminster, London, UK. people suffer from ME in the UK Invest in ME welcomes delegates, presenters and media from ten countries around the world to the conference – emphasising that ME recognises no international boundaries. The interest in the conference also demonstrates the need for some of IiME’s main objectives – more education and proper funding for biomedical research into ME. In this document we include articles from renowned ME experts who ME Story were not able to be present at the conference this year as well as those who are. We also include other ME experts who are presenting. IiME I fell ill with the flu the hope to publish our journal throughout the year. As with the IiME same time as Antony, conference it will allow a platform for researchers, scientists, healthcare my then staff and politicians to be able to share and provide information boyfriend/fiancé. He relevant to those supporting, campaigning for or suffering from ME. -
Parliamentary-Briefi
1 Briefing for ‘Myalgic Encephalomyelitis: Treatment and Research’ Westminster Hall, 21st June 2018 Contents About ME 3 The Debate 3 Education of health professionals 4 Review of the NICE guideline on ME/CFS 5 NHS services 6 Children and young people with ME 7 Severe ME 7 Biomedical research 8 PACE trial 10 ME and welfare benefits 10 Social Care 11 References 13 Contact details 15 Appendix: The PACE Trial Controversy 16 This briefing has been produced jointly by #MEAction, Action for M.E., ME Association and the ME Trust (for contact details, see page 15) Supported by: Blue Ribbon for Awareness of ME, Centre for Welfare Reform, Forward-ME, ME Research UK, WAMES, Hope 4 ME & Fibro Northern Ireland 2 About ME Myalgic Encephalomyelitis (ME) is a chronic, fluctuating, neurological condition that causes symptoms affecting many body systems, more commonly the nervous and immune systems. ME affects an estimated 250,000 adults and children in the UK, and around 17 million people worldwide. People with ME experience severe, persistent fatigue associated with post-exertional malaise (PEM), their systems’ inability to recover after expending even small amounts of energy, leading to a flare-up in symptoms. PEM means that simple mental or physical activities can leave people with ME debilitated, experiencing a range of symptoms that are not significantly relieved by resting. PEM is the hallmark symptom of ME, other symptoms can include muscle and joint pain, cognitive difficulties, noise and light sensitivities and digestive problems. People with ME can vary enormously in their experience of the illness, and how their symptoms fluctuate. -
Briefing for ‘Myalgic Encephalomyelitis: Treatment St and Research’ Westminster Hall, 21 June 2018
1 Briefing for ‘Myalgic Encephalomyelitis: Treatment st and Research’ Westminster Hall, 21 June 2018 Contents About ME 3 The Debate 3 Education of health professionals 4 Review of the NICE guideline on ME/CFS 5 NHS services 6 Children and young people with ME 7 Severe ME 7 Biomedical research 8 PACE trial 10 ME and welfare benefits 10 Social Care 11 References 13 Contact details 15 Appendix: The PACE Trial Controversy 16 This briefing has been produced jointly by #MEAction, Action for M.E., ME Association and the ME Trust (for contact details, see page 15) Supported by: Blue Ribbon for Awareness of ME, Centre for Welfare Reform, Forward-ME, ME Research UK, WAMES, Hope 4 ME & Fibro Northern Ireland 2 A bout ME Myalgic Encephalomyelitis (ME) is a chronic, fluctuating, neurological condition that causes symptoms affecting many body systems, more commonly the nervous and immune systems. ME affects an estimated 250,000 adults and children in the UK, and around 17 million people worldwide. People with ME experience severe, persistent fatigue associated with post-exertional malaise (PEM), their systems’ inability to recover after expending even small amounts of energy, leading to a flare-up in symptoms. PEM means that simple mental or physical activities can leave people with ME debilitated, experiencing a range of symptoms that are not significantly relieved by resting. PEM is the hallmark symptom of ME, other symptoms can include muscle and joint pain, cognitive difficulties, noise and light sensitivities and digestive problems. People with ME can vary enormously in their experience of the illness, and how their symptoms fluctuate. -
The Psychological Aspects and Management of Chronic Fatigue Syndrome
THE PSYCHOLOGICAL ASPECTS AND MANAGEMENT OF CHRONIC FATIGUE SYNDROME A Thesis submitted for the degree of Doctor of Philosophy by Ellen Marianne Goudsmit Department of Human Sciences, Brunel University February 1996 ACKNOWLEDGEMENTS The three studies could not have been completed without the help of a large number of people. First of all, I would like to thank my supervisors, Dr. Colette Ray and Mr. Ian Robinson, who have guided me with great skill and infinite patience. I am also grateful to Dr. Elizabeth Dowsett, Dr. Gordon Parish and Dr. Darryl Ho-Yen, who not only gave me practical assistance and scientific advice, but who also encouraged and supported me throughout. Thanks are also due to Lorna Wycherley for sending out the questionnaires for Study 3, to the staff at Richmond and Teddington libraries who obtained several hundred articles and books for me, to the Training Agency who loaned me a computer and printer, to Dr. Inge Heinrich and the support team at Brunel's Computer Centre for their statistical advice, to Frouke Bates and to Action for M.E. who funded Study 2. Finally, I wish to thank my parents, Abraham and Felicie Goudsmit, for all their help during the past six years, my friends, Deana Goff and Sandra Howes for their continuing interest and support and my colleagues, Drs. Charles Shepherd and Anne Macintyre for helping me make sense of a very complex subject. Most of all, I would like to thank everyone who took part in the studies for their time and their trust. Without their co-operation, this research would not have been possible.